{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:44:18Z","timestamp":1768520658254,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It is unknown whether the presence of metabolic syndrome (MetS) affects the incidence of laryngeal cancer. The aim of this national population-based retrospective study was to analyze the relationship between MetS and the incidence of laryngeal cancer. Patients with laryngeal cancer (ICD-10: C32) between 2009 and 2010 were retrospectively identified and tracked until 2015 using the Korean Health Insurance claims database. During the seven-year follow-up period, 5,322 subjects were newly diagnosed with larynx cancer. The mean age of people with laryngeal cancer was much higher than those without (63.29 vs. 47.7 years, p\u2009&lt;\u20090.0001), and the incidence of larynx cancer in men was much higher than that in women (93.16% vs. 6.84%, p\u2009&lt;\u20090.0001). Age, gender, smoking status, alcohol intake, and exercise-adjusted hazard ratios indicated that participants with MetS had a 1.13-fold higher hazard of having larynx cancer than those without MetS. The number of MetS components was a strong risk factor for laryngeal cancer with a higher risk estimate of this cancer in both ex- and current smokers as well as people who have never smoked. MetS was found to be an independent risk factor for the incidence of laryngeal cancer. In Korea, MetS and its components are significantly associated with the development of laryngeal cancer.<\/jats:p>","DOI":"10.1038\/s41598-018-37061-0","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T11:04:17Z","timestamp":1548327857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Metabolic Syndrome and Incidence of Laryngeal Cancer: A Nationwide Cohort Study"],"prefix":"10.1038","volume":"9","author":[{"given":"Sang-Yeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-do","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1158-0974","authenticated-orcid":false,"given":"Young-Hoon","family":"Joo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"37061_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics. CA Cancer J Clin. 66, 7\u201330 (2016).","journal-title":"CA Cancer J Clin."},{"key":"37061_CR2","first-page":"30112","volume":"S1871\u20134021","author":"NV Yunusova","year":"2018","unstructured":"Yunusova, N. V. et al. The role of metabolic syndrome variant in the malignant tumors progression. Diabetes Metab Syndr. S1871\u20134021, 30112\u20137 (2018).","journal-title":"Diabetes Metab Syndr."},{"key":"37061_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/sj.ejcn.1600700","volume":"53","author":"BA Stoll","year":"1999","unstructured":"Stoll, B. A. Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr. 53, 83\u20137 (1999).","journal-title":"Eur J Clin Nutr."},{"key":"37061_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 4, 579\u201391 (2004).","journal-title":"Nat Rev Cancer."},{"key":"37061_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jama.293.2.194","volume":"293","author":"SH Jee","year":"2005","unstructured":"Jee, S. H. et al. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 293, 194\u2013202 (2005).","journal-title":"JAMA."},{"key":"37061_CR6","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1001\/archinte.166.17.1871","volume":"166","author":"M Inoue","year":"2006","unstructured":"Inoue, M. et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 166, 1871\u20137 (2006).","journal-title":"Arch Intern Med."},{"key":"37061_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.cgh.2006.06.022","volume":"5","author":"HM Chiu","year":"2007","unstructured":"Chiu, H. M. et al. Association of metabolic syndrome with proximal and synchronous colorectal neoplasm. Clin Gastroenterol Hepatol. 5, 221\u20139 (2007).","journal-title":"Clin Gastroenterol Hepatol."},{"key":"37061_CR8","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1158\/1055-9965.1646.13.10","volume":"13","author":"JA Laukkanen","year":"2004","unstructured":"Laukkanen, J. A. et al. Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study. Cancer Epidemiol Biomarkers Prev. 13, 1646\u201350 (2004).","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"37061_CR9","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/aje\/kwj284","volume":"164","author":"L Lund H\u00e5heim","year":"2006","unstructured":"Lund H\u00e5heim, L., Wisl\u00f8ff, T. F., Holme, I. & Nafstad, P. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol. 164, 769\u201374 (2006).","journal-title":"Am J Epidemiol."},{"key":"37061_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ijc.21812","volume":"119","author":"P Pasanisi","year":"2006","unstructured":"Pasanisi, P. et al. Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer. 119, 236\u20138 (2006).","journal-title":"Int J Cancer."},{"key":"37061_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1158\/1055-9965.EPI-14-0923","volume":"24","author":"B Trabert","year":"2015","unstructured":"Trabert, B. et al. Metabolic syndrome and risk of endometrial cancer in the united states: a study in the SEER-medicare linked database. Cancer Epidemiol Biomarkers Prev. 24, 261\u20137 (2015).","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"37061_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1463-1318.2005.00747.x","volume":"7","author":"AK Samad","year":"2005","unstructured":"Samad, A. K., Taylor, R. S., Marshall, T. & Chapman, M. A. A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis. 7, 204\u201313 (2005).","journal-title":"Colorectal Dis."},{"key":"37061_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/BF03346748","volume":"36","author":"K Esposito","year":"2013","unstructured":"Esposito, K. et al. Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis. J Endocrinol Invest. 36, 132\u20139 (2013).","journal-title":"J Endocrinol Invest."},{"key":"37061_CR14","unstructured":"Korean Association of Smoking and Health. National Smoking Prevalence Survey. Available, http:\/\/www.kash.or.kr\/user_new\/main.asp."},{"key":"37061_CR15","first-page":"6502","volume":"50","author":"S Franceschi","year":"1990","unstructured":"Franceschi, S. et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in Northern Italy. Cancer Res 50, 6502\u20136507 (1990).","journal-title":"Cancer Res"},{"key":"37061_CR16","doi-asserted-by":"crossref","unstructured":"Bellastella, G., Scappaticcio, L., Esposito, K., Giugliano, D. & Maiorino, M. I. Metabolic syndrome and cancer: The common soil hypothesis. Diabetes Res Clin Pract. [Epub ahead of print] (26 May 2018).","DOI":"10.1016\/j.diabres.2018.05.024"},{"key":"37061_CR17","first-page":"3963","volume":"17","author":"NV Yunusova","year":"2016","unstructured":"Yunusova, N. V. et al. Association of IGFBP-6 Expression with Metabolic Syndrome and Adiponectin and IGF-IR Receptor Levels in Colorectal Cancer. Asian Pac J Cancer Prev. 17, 3963\u20139 (2016).","journal-title":"Asian Pac J Cancer Prev."},{"key":"37061_CR18","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.2217\/fon.10.87","volume":"6","author":"LM Berstein","year":"2010","unstructured":"Berstein, L. M. Modern approach to metabolic rehabilitation of cancer patients: biguanides (phenformin and metformin) and beyond. Future Oncol. 6, 1313\u201323 (2010).","journal-title":"Future Oncol."},{"key":"37061_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.18865\/ed.25.4.383","volume":"25","author":"PP Chia","year":"2015","unstructured":"Chia, P. P., Fan, S. H. & Say, Y. H. Screening of Peroxisome Proliferator-Activated Receptors (PPARs) alpha, gamma and alpha Gene Polymorphisms for Obesity and Metabolic Syndrome Association in the Multi-Ethnic Malaysian Population. Ethn Dis. 25, 383\u201390 (2015).","journal-title":"Ethn Dis."},{"key":"37061_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1349-7006.2008.01053.x","volume":"100","author":"J Gao","year":"2009","unstructured":"Gao, J. et al. Leptin induces functional activation of cyclooxygenase-2 through JAK2\/STAT3, MAPK\/ERK, and PI3K\/AKT pathways in human endometrial cancer cells. Cancer Sci. 100, 389\u201395 (2009).","journal-title":"Cancer Sci."},{"key":"37061_CR21","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1210\/me.2009-0498","volume":"24","author":"AY Kim","year":"2010","unstructured":"Kim, A. Y. et al. Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol Endocrinol. 24, 1441\u201352 (2010).","journal-title":"Mol Endocrinol."},{"key":"37061_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ygyno.2016.07.109","volume":"143","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K\/Akt and MAPK\/ERK1\/2 signalling pathways. Gynecol Oncol. 143, 168\u201378 (2016).","journal-title":"Gynecol Oncol."},{"key":"37061_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi, N., Parker, J. L., Lugus, J. J. & Walsh, K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 11, 85\u201397 (2011).","journal-title":"Nat Rev Immunol."},{"key":"37061_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.metabol.2014.10.008","volume":"64","author":"FM Mendonca","year":"2015","unstructured":"Mendonca, F. M. et al. Metabolic syndrome and risk of cancer: which link? Metabolism. 64, 182\u20139 (2015).","journal-title":"Metabolism."},{"key":"37061_CR25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.7150\/ijbs.7.1003","volume":"7","author":"S Braun","year":"2011","unstructured":"Braun, S., Bitton-Worms, K. & LeRoith, D. The link between the metabolic syndrome and cancer. Int J Biol Sci. 7, 1003\u201315 (2011).","journal-title":"Int J Biol Sci."},{"key":"37061_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/19371910903070333","volume":"25","author":"DS Kim","year":"2010","unstructured":"Kim, D. S. Introduction: health of the health care system in Korea. Soc Work Public Health 25, 127\u201341 (2010).","journal-title":"Soc Work Public Health"},{"key":"37061_CR27","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/jth.12611","volume":"12","author":"HY Yhim","year":"2014","unstructured":"Yhim, H. Y. et al. Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost 12, 1035\u201343 (2014).","journal-title":"J Thromb Haemost"},{"key":"37061_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"A KGMM","year":"2006","unstructured":"KGMM, A., Zimmet, P. & Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 23, 469\u201380 (2006).","journal-title":"Diabet Med."},{"key":"37061_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.tem.2006.08.006","volume":"17","author":"AG Renehan","year":"2006","unstructured":"Renehan, A. G., Frystyk, J. & Flyvbjerg, A. Obesity and cancer risk: the role of the insulin\u2013IGF axis. Trends Endocrinol Metab. 17, 328\u201336 (2006).","journal-title":"Trends Endocrinol Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37061-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:21:59Z","timestamp":1671254519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37061-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37061"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37061-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"19 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"667"}}